|
Gender: male/female
|
1.45 (0.55–3.83)
|
0.456
| | |
|
Age at operation
|
1.02 (0.98–1.07)
|
0.347
| | |
|
ASA score (I-II/III-IV)
|
1.47 (0.48–4.50)
|
0.499
| | |
|
Body mass index
|
1.08 (0.90–1.28)
|
0.342
| | |
|
Preoperative chemotherapy (no/yes)
|
1.76 (0.52–5.92)
|
0.360
| | |
|
Site of original (colon/rectum)
|
2.47 (0.88–7.0)
|
0.087
| | |
|
Liver metastases (no/yes)
|
1.28 (0.40–4.14)
|
0.687
| | |
|
HIPEC regimen (lobaplatin/non-lobaplatin)
|
0.48 (0.17–1.40)
|
0.177
| | |
|
Operative time
|
1.01 (0.99–1.01)
|
0.164
| | |
|
Estimated blood loss
|
1.62 (1.21–2.04)
|
< 0.001
|
1.41 (1.13–1.82)
|
< 0.001
|
|
Presence of ascites (no/yes)
|
1.14 (0.43–3.03)
|
0.790
| | |
|
PCI score
|
1.12 (1.03–1.20)
|
0.008
|
1.22 (0.95–1.44)
|
0.085
|
|
CC score (0–1/2–3)
|
0.76 (0.28–2.05)
|
0.582
| | |
